KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Overview Fund Activity
Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

94 hedge funds and large institutions have $273M invested in Chinook Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
+4
Holders Change %
+4.44%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
35
Reduced
23
Closed
14
Calls
$461K
Puts
$201K
Net Calls
+$260K
Net Calls Change
-$305K

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
$17M
2
Vanguard Group
Vanguard Group
Pennsylvania
$25.9M
3
Wellington Management Group
Wellington Management Group
Massachusetts
$79.1M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
$7.82M
5
State Street
State Street
Massachusetts
$13.2M

Top Sellers

1
HMC
Harvard Management Company
Massachusetts
$31.3M
2
O
OppenheimerFunds
New York
$0
3
BI
BVF Inc
California
$0
4
AC
Ascend Capital
California
$0
5
William Blair & Company
William Blair & Company
Illinois
$727K
Name Holding Trade Value Shares
Change 		Shares
Change %
Russell Investments Group
101
Russell Investments Group
United Kingdom
– -$124K -2,327 Closed
ZIM
102
Zacks Investment Management
Illinois
– -$118K -2,210 Closed
CHP
103
Cable Hill Partners
Oregon
– -$8K -150 Closed
1 2 3 4
5